Burton Paul Frederick 4
Research Summary
AI-generated summary
Cardio Diagnostics (CDIO) Director Burton Frederick Receives Award of 3,205 Shares
What Happened
- Burton Paul Frederick, a director of Cardio Diagnostics Holdings, Inc. (CDIO), was reported on Form 4 as acquiring 3,205 shares on March 31, 2026. The shares are recorded at $1.95 each, for a total reported value of $6,250.
- The transaction is coded as an "A" (award/grant/other acquisition), indicating the shares were received through an award or similar issuance (a derivative settlement or grant), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-03-31; Filing date: 2026-04-02 (filed within the standard Form 4 window).
- Price per share: $1.95; Shares acquired: 3,205; Reported total value: $6,250.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Footnotes/tax withholding: none reported in the excerpt provided.
- Transaction type code: A = Award/Grant/Other acquisition (derivative/compensation-related).
Context
- Awards to directors are typically part of compensation or equity-based retention plans and do not necessarily indicate the insider's short-term trading view. The dollar value here is modest (~$6.3k).
- For retail investors, treat awards differently from open-market purchases: awards signal company compensation decisions, while outright purchases may be a stronger indication of personal conviction.